APGE

Apogee Therapeutics, Inc.

Insider trading activity for Apogee Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

-$4.1M

net selling

Bought(0 · 0 insiders): $0
Sold(3 · 2 insiders): $4.1M

Past 6 months

-$25.1M

net selling

Bought(0 · 0 insiders): $0
Sold(28 · 3 insiders): $25.1M

Past 12 months

-$174.2M

net selling

Bought(0 · 0 insiders): $0
Sold(83 · 4 insiders): $174.2M

Transaction history

The 100 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 3	Fairmount Funds…	Director	DTOISS◆	7,657	—	—	—	Open the original filing on SEC.gov
Sep 3	Fairmount Funds…	Director	DTOISS◆	14,461	—	—	—	Open the original filing on SEC.gov
Sep 3	Fairmount Funds…	Director	DTOISS◆	10,370	—	—	—	Open the original filing on SEC.gov
Sep 3	Fairmount Funds…	Director	DTOISS◆	47,758	—	—	—	Open the original filing on SEC.gov
Sep 3	Fairmount Funds…	Director	DTOISS◆	6.7M	—	—	—	Open the original filing on SEC.gov
Sep 3	Fairmount Funds…	Director	DTOISS	51,166	—	—	-100.0%	Open the original filing on SEC.gov
Sep 3	Fairmount Funds…	Director	DTOISS	51,166	—	—	-100.0%	Open the original filing on SEC.gov
Sep 3	Fairmount Funds…	Director	DTOISS	340,855	—	—	-100.0%	Open the original filing on SEC.gov
Aug 7	Fairmount Funds…	Director	MEXER◆	10,370	—	—	—	Open the original filing on SEC.gov
Aug 7	Fairmount Funds…	Director	MEXER◆	31,838	—	—	—	Open the original filing on SEC.gov
Aug 7	Fairmount Funds…	Director	MEXER	10,370	$43.85	$454.7K	+3.1%	Open the original filing on SEC.gov
Aug 7	Fairmount Funds…	Director	MEXER	31,838	$17.00	$541.2K	+10.7%	Open the original filing on SEC.gov
Aug 5	Dambkowski Carl	Chief Medical Officer	MEXER◷◆	4,125	—	—	—	Open the original filing on SEC.gov
Aug 5	Dambkowski Carl	Chief Medical Officer	SSELL◷	5,500	$134.17	$737.9K	-3.2%	Open the original filing on SEC.gov
Aug 5	Dambkowski Carl	Chief Medical Officer	MEXER◷	4,125	$22.86	$94.3K	+2.4%	Open the original filing on SEC.gov
Jul 24	Henderson Jane	Chief Financial Officer	GGIFT	15,000	—	—	-8.6%	Open the original filing on SEC.gov
Jul 14	Dambkowski Carl	Chief Medical Officer	GGIFT	8,000	—	—	-4.5%	Open the original filing on SEC.gov
Jul 10	Henderson Michael Thomas	Chief Executive Officer	GGIFT◷	75,046	—	—	-7.5%	Open the original filing on SEC.gov
Jul 8	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	20,000	$133.63	$2.7M	-2.0%	Open the original filing on SEC.gov
Jul 1	Dambkowski Carl	Chief Medical Officer	MEXER◷◆	4,125	—	—	—	Open the original filing on SEC.gov
Jul 1	Dambkowski Carl	Chief Medical Officer	SSELL◷	5,500	$132.74	$730.1K	-3.0%	Open the original filing on SEC.gov
Jul 1	Dambkowski Carl	Chief Medical Officer	MEXER◷	4,125	$22.86	$94.3K	+2.3%	Open the original filing on SEC.gov
Jun 22	Dambkowski Carl	Chief Medical Officer	SSELL◷	26,400	$132.60	$3.5M	-12.8%	Open the original filing on SEC.gov
Jun 22	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	80,000	$132.54	$10.6M	-7.3%	Open the original filing on SEC.gov
Jun 10	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	614	$86.89	$53.4K	<0.1%	Open the original filing on SEC.gov
Jun 10	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	2,305	$86.27	$198.9K	-0.2%	Open the original filing on SEC.gov
Jun 10	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	1,577	$85.19	$134.3K	-0.1%	Open the original filing on SEC.gov
Jun 10	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	1,080	$84.18	$90.9K	-0.1%	Open the original filing on SEC.gov
Jun 10	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	7,654	$82.78	$633.6K	-0.7%	Open the original filing on SEC.gov
Jun 10	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	6,770	$82.21	$556.6K	-0.6%	Open the original filing on SEC.gov
Jun 9	Fairmount Funds…	Director	AGRANT◆	7,657	—	—	—	Open the original filing on SEC.gov
Jun 9	Shah Nimish P	Director	AGRANT◆	7,657	—	—	—	Open the original filing on SEC.gov
Jun 9	McKenna Mark C.	Director	AGRANT◆	7,657	—	—	—	Open the original filing on SEC.gov
Jun 9	Jones William A Jr	Director	AGRANT◆	7,657	—	—	—	Open the original filing on SEC.gov
Jun 9	Fox Jennifer A.	Director	AGRANT◆	7,657	—	—	—	Open the original filing on SEC.gov
Jun 9	Bollinger Lisa	Director	AGRANT◆	7,657	—	—	—	Open the original filing on SEC.gov
Jun 3	Dambkowski Carl	Chief Medical Officer	MEXER◷◆	4,125	—	—	—	Open the original filing on SEC.gov
Jun 3	Dambkowski Carl	Chief Medical Officer	SSELL◷	5,500	$78.71	$432.9K	-2.6%	Open the original filing on SEC.gov
Jun 3	Dambkowski Carl	Chief Medical Officer	MEXER◷	4,125	$22.86	$94.3K	+2.0%	Open the original filing on SEC.gov
May 13	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	1,341	$82.58	$110.7K	-0.1%	Open the original filing on SEC.gov
May 13	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	18,659	$82.05	$1.5M	-1.6%	Open the original filing on SEC.gov
May 6	Dambkowski Carl	Chief Medical Officer	MEXER◷◆	4,125	—	—	—	Open the original filing on SEC.gov
May 6	Dambkowski Carl	Chief Medical Officer	SSELL◷	1,800	$84.60	$152.3K	-0.9%	Open the original filing on SEC.gov
May 6	Dambkowski Carl	Chief Medical Officer	SSELL◷	3,700	$83.92	$310.5K	-1.7%	Open the original filing on SEC.gov
May 6	Dambkowski Carl	Chief Medical Officer	MEXER◷	4,125	$22.86	$94.3K	+2.0%	Open the original filing on SEC.gov
May 1	Henderson Jane	Chief Financial Officer	SSELL◷	289	$83.16	$24K	-0.2%	Open the original filing on SEC.gov
May 1	Henderson Jane	Chief Financial Officer	SSELL◷	900	$82.60	$74.3K	-0.5%	Open the original filing on SEC.gov
May 1	Henderson Jane	Chief Financial Officer	SSELL◷	811	$81.02	$65.7K	-0.5%	Open the original filing on SEC.gov
Apr 16	Henderson Jane	Chief Financial Officer	SSELL◷	2,000	$90.00	$180K	-1.1%	Open the original filing on SEC.gov
Apr 16	Henderson Michael Thomas	Chief Executive Officer	MEXER◆	3,000	—	—	—	Open the original filing on SEC.gov
Apr 16	Henderson Michael Thomas	Chief Executive Officer	MEXER	3,000	$22.86	$68.6K	+0.3%	Open the original filing on SEC.gov
Apr 8	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	200	$85.00	$17K	<0.1%	Open the original filing on SEC.gov
Apr 8	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	2,000	$83.26	$166.5K	-0.2%	Open the original filing on SEC.gov
Apr 8	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	17,800	$82.48	$1.5M	-1.5%	Open the original filing on SEC.gov
Apr 1	Dambkowski Carl	Chief Medical Officer	MEXER◷◆	4,125	—	—	—	Open the original filing on SEC.gov
Apr 1	Dambkowski Carl	Chief Medical Officer	SSELL◷	100	$85.89	$8.6K	<0.1%	Open the original filing on SEC.gov
Apr 1	Dambkowski Carl	Chief Medical Officer	SSELL◷	2,702	$85.33	$230.6K	-1.3%	Open the original filing on SEC.gov
Apr 1	Dambkowski Carl	Chief Medical Officer	SSELL◷	2,698	$84.31	$227.5K	-1.3%	Open the original filing on SEC.gov
Apr 1	Dambkowski Carl	Chief Medical Officer	MEXER◷	4,125	$22.86	$94.3K	+2.0%	Open the original filing on SEC.gov
Apr 1	Henderson Jane	Chief Financial Officer	SSELL◷	1,100	$85.46	$94K	-0.6%	Open the original filing on SEC.gov
Apr 1	Henderson Jane	Chief Financial Officer	SSELL◷	900	$84.46	$76K	-0.5%	Open the original filing on SEC.gov
Mar 25	Henderson Jane	Chief Financial Officer	SSELL◷	2,000	$85.00	$170K	-1.1%	Open the original filing on SEC.gov
Mar 11	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	3,418	$75.86	$259.3K	-0.3%	Open the original filing on SEC.gov
Mar 11	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	8,219	$74.83	$615K	-0.7%	Open the original filing on SEC.gov
Mar 11	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	8,363	$74.29	$621.3K	-0.7%	Open the original filing on SEC.gov
Mar 4	Dambkowski Carl	Chief Medical Officer	MEXER◷◆	4,125	—	—	—	Open the original filing on SEC.gov
Mar 4	Dambkowski Carl	Chief Medical Officer	SSELL◷	200	$73.26	$14.7K	-0.1%	Open the original filing on SEC.gov
Mar 4	Dambkowski Carl	Chief Medical Officer	SSELL◷	2,075	$71.98	$149.4K	-1.0%	Open the original filing on SEC.gov
Mar 4	Dambkowski Carl	Chief Medical Officer	SSELL◷	3,225	$70.33	$226.8K	-1.5%	Open the original filing on SEC.gov
Mar 4	Dambkowski Carl	Chief Medical Officer	MEXER◷	4,125	$22.86	$94.3K	+1.9%	Open the original filing on SEC.gov
Mar 2	Henderson Jane	Chief Financial Officer	SSELL◷	406	$71.66	$29.1K	-0.2%	Open the original filing on SEC.gov
Mar 2	Henderson Jane	Chief Financial Officer	SSELL◷	994	$70.45	$70K	-0.5%	Open the original filing on SEC.gov
Mar 2	Henderson Jane	Chief Financial Officer	SSELL◷	300	$69.43	$20.8K	-0.2%	Open the original filing on SEC.gov
Mar 2	Henderson Jane	Chief Financial Officer	SSELL◷	300	$68.27	$20.5K	-0.2%	Open the original filing on SEC.gov
Feb 11	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	955	$64.99	$62.1K	<0.1%	Open the original filing on SEC.gov
Feb 11	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	7,551	$63.73	$481.2K	-0.6%	Open the original filing on SEC.gov
Feb 11	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	11,494	$62.96	$723.7K	-1.0%	Open the original filing on SEC.gov
Feb 4	Dambkowski Carl	Chief Medical Officer	MEXER◷◆	4,125	—	—	—	Open the original filing on SEC.gov
Feb 4	Dambkowski Carl	Chief Medical Officer	SSELL◷	200	$68.94	$13.8K	<0.1%	Open the original filing on SEC.gov
Feb 4	Dambkowski Carl	Chief Medical Officer	SSELL◷	100	$67.88	$6.8K	<0.1%	Open the original filing on SEC.gov
Feb 4	Dambkowski Carl	Chief Medical Officer	SSELL◷	1,299	$66.85	$86.8K	-0.6%	Open the original filing on SEC.gov
Feb 4	Dambkowski Carl	Chief Medical Officer	SSELL◷	1,420	$65.83	$93.5K	-0.7%	Open the original filing on SEC.gov
Feb 4	Dambkowski Carl	Chief Medical Officer	SSELL◷	2,481	$64.88	$161K	-1.1%	Open the original filing on SEC.gov
Feb 4	Dambkowski Carl	Chief Medical Officer	MEXER◷	4,125	$22.86	$94.3K	+1.9%	Open the original filing on SEC.gov
Feb 2	Henderson Jane	Chief Financial Officer	SSELL◷	100	$66.89	$6.7K	<0.1%	Open the original filing on SEC.gov
Feb 2	Henderson Jane	Chief Financial Officer	SSELL◷	1,108	$66.15	$73.3K	-0.6%	Open the original filing on SEC.gov
Feb 2	Henderson Jane	Chief Financial Officer	SSELL◷	792	$65.21	$51.6K	-0.4%	Open the original filing on SEC.gov
Jan 22	Fairmount Funds…	Director	SSELL	1.8M	$76.30	$133.5M	-85.4%	Open the original filing on SEC.gov
Jan 14	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	470	$83.79	$39.4K	<0.1%	Open the original filing on SEC.gov
Jan 14	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	5,386	$83.16	$447.9K	-0.4%	Open the original filing on SEC.gov
Jan 14	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	1,854	$82.41	$152.8K	-0.1%	Open the original filing on SEC.gov
Jan 14	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	2,374	$81.00	$192.3K	-0.2%	Open the original filing on SEC.gov
Jan 14	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	8,476	$79.82	$676.6K	-0.7%	Open the original filing on SEC.gov
Jan 14	Henderson Michael Thomas	Chief Executive Officer	SSELL◷	1,440	$78.64	$113.2K	-0.1%	Open the original filing on SEC.gov
Jan 7	Dambkowski Carl	Chief Medical Officer	MEXER◷◆	14,025	—	—	—	Open the original filing on SEC.gov
Jan 7	Dambkowski Carl	Chief Medical Officer	SSELL◷	100	$80.06	$8K	<0.1%	Open the original filing on SEC.gov
Jan 7	Dambkowski Carl	Chief Medical Officer	SSELL◷	826	$79.04	$65.3K	-0.4%	Open the original filing on SEC.gov
Jan 7	Dambkowski Carl	Chief Medical Officer	SSELL◷	14,820	$77.90	$1.2M	-6.5%	Open the original filing on SEC.gov
Jan 7	Dambkowski Carl	Chief Medical Officer	SSELL◷	2,954	$77.13	$227.8K	-1.3%	Open the original filing on SEC.gov
Jan 7	Dambkowski Carl	Chief Medical Officer	MEXER◷	14,025	$22.86	$320.6K	+6.5%	Open the original filing on SEC.gov

DTOISS◆—

Fairmount Funds… · DirectorSep 3

7,657 sh

DTOISS◆—

Fairmount Funds… · DirectorSep 3

14,461 sh

DTOISS◆—

Fairmount Funds… · DirectorSep 3

10,370 sh

DTOISS◆—

Fairmount Funds… · DirectorSep 3

47,758 sh

DTOISS◆—

Fairmount Funds… · DirectorSep 3

6.7M sh

DTOISS—

Fairmount Funds… · DirectorSep 3

51,166 sh · -100.0% own

DTOISS—

Fairmount Funds… · DirectorSep 3

51,166 sh · -100.0% own

DTOISS—

Fairmount Funds… · DirectorSep 3

340,855 sh · -100.0% own

MEXER◆—

Fairmount Funds… · DirectorAug 7

10,370 sh

MEXER◆—

Fairmount Funds… · DirectorAug 7

31,838 sh

MEXER$454.7K

Fairmount Funds… · DirectorAug 7

10,370 sh @ $43.85 · +3.1% own

MEXER$541.2K

Fairmount Funds… · DirectorAug 7

31,838 sh @ $17.00 · +10.7% own

MEXER◷◆—

Dambkowski Carl · Chief Medical…Aug 5

4,125 sh

SSELL◷$737.9K

Dambkowski Carl · Chief Medical…Aug 5

5,500 sh @ $134.17 · -3.2% own

MEXER◷$94.3K

Dambkowski Carl · Chief Medical…Aug 5

4,125 sh @ $22.86 · +2.4% own

GGIFT—

Henderson Jane · Chief Financial…Jul 24

15,000 sh · -8.6% own

GGIFT—

Dambkowski Carl · Chief Medical…Jul 14

8,000 sh · -4.5% own

GGIFT◷—

Henderson Michael Thomas · Chief Executive…Jul 10

75,046 sh · -7.5% own

SSELL◷$2.7M

Henderson Michael Thomas · Chief Executive…Jul 8

20,000 sh @ $133.63 · -2.0% own

MEXER◷◆—

Dambkowski Carl · Chief Medical…Jul 1

4,125 sh

SSELL◷$730.1K

Dambkowski Carl · Chief Medical…Jul 1

5,500 sh @ $132.74 · -3.0% own

MEXER◷$94.3K

Dambkowski Carl · Chief Medical…Jul 1

4,125 sh @ $22.86 · +2.3% own

SSELL◷$3.5M

Dambkowski Carl · Chief Medical…Jun 22

26,400 sh @ $132.60 · -12.8% own

SSELL◷$10.6M

Henderson Michael Thomas · Chief Executive…Jun 22

80,000 sh @ $132.54 · -7.3% own

SSELL◷$53.4K

Henderson Michael Thomas · Chief Executive…Jun 10

614 sh @ $86.89 · <0.1% own

SSELL◷$198.9K

Henderson Michael Thomas · Chief Executive…Jun 10

2,305 sh @ $86.27 · -0.2% own

SSELL◷$134.3K

Henderson Michael Thomas · Chief Executive…Jun 10

1,577 sh @ $85.19 · -0.1% own

SSELL◷$90.9K

Henderson Michael Thomas · Chief Executive…Jun 10

1,080 sh @ $84.18 · -0.1% own

SSELL◷$633.6K

Henderson Michael Thomas · Chief Executive…Jun 10

7,654 sh @ $82.78 · -0.7% own

SSELL◷$556.6K

Henderson Michael Thomas · Chief Executive…Jun 10

6,770 sh @ $82.21 · -0.6% own

AGRANT◆—

Fairmount Funds… · DirectorJun 9

7,657 sh

AGRANT◆—

Shah Nimish P · DirectorJun 9

7,657 sh

AGRANT◆—

McKenna Mark C. · DirectorJun 9

7,657 sh

AGRANT◆—

Jones William A Jr · DirectorJun 9

7,657 sh

AGRANT◆—

Fox Jennifer A. · DirectorJun 9

7,657 sh

AGRANT◆—

Bollinger Lisa · DirectorJun 9

7,657 sh

MEXER◷◆—

Dambkowski Carl · Chief Medical…Jun 3

4,125 sh

SSELL◷$432.9K

Dambkowski Carl · Chief Medical…Jun 3

5,500 sh @ $78.71 · -2.6% own

MEXER◷$94.3K

Dambkowski Carl · Chief Medical…Jun 3

4,125 sh @ $22.86 · +2.0% own

SSELL◷$110.7K

Henderson Michael Thomas · Chief Executive…May 13

1,341 sh @ $82.58 · -0.1% own

SSELL◷$1.5M

Henderson Michael Thomas · Chief Executive…May 13

18,659 sh @ $82.05 · -1.6% own

MEXER◷◆—

Dambkowski Carl · Chief Medical…May 6

4,125 sh

SSELL◷$152.3K

Dambkowski Carl · Chief Medical…May 6

1,800 sh @ $84.60 · -0.9% own

SSELL◷$310.5K

Dambkowski Carl · Chief Medical…May 6

3,700 sh @ $83.92 · -1.7% own

MEXER◷$94.3K

Dambkowski Carl · Chief Medical…May 6

4,125 sh @ $22.86 · +2.0% own

SSELL◷$24K

Henderson Jane · Chief Financial…May 1

289 sh @ $83.16 · -0.2% own

SSELL◷$74.3K

Henderson Jane · Chief Financial…May 1

900 sh @ $82.60 · -0.5% own

SSELL◷$65.7K

Henderson Jane · Chief Financial…May 1

811 sh @ $81.02 · -0.5% own

SSELL◷$180K

Henderson Jane · Chief Financial…Apr 16

2,000 sh @ $90.00 · -1.1% own

MEXER◆—

Henderson Michael Thomas · Chief Executive…Apr 16

3,000 sh

MEXER$68.6K

Henderson Michael Thomas · Chief Executive…Apr 16

3,000 sh @ $22.86 · +0.3% own

SSELL◷$17K

Henderson Michael Thomas · Chief Executive…Apr 8

200 sh @ $85.00 · <0.1% own

SSELL◷$166.5K

Henderson Michael Thomas · Chief Executive…Apr 8

2,000 sh @ $83.26 · -0.2% own

SSELL◷$1.5M

Henderson Michael Thomas · Chief Executive…Apr 8

17,800 sh @ $82.48 · -1.5% own

MEXER◷◆—

Dambkowski Carl · Chief Medical…Apr 1

4,125 sh

SSELL◷$8.6K

Dambkowski Carl · Chief Medical…Apr 1

100 sh @ $85.89 · <0.1% own

SSELL◷$230.6K

Dambkowski Carl · Chief Medical…Apr 1

2,702 sh @ $85.33 · -1.3% own

SSELL◷$227.5K

Dambkowski Carl · Chief Medical…Apr 1

2,698 sh @ $84.31 · -1.3% own

MEXER◷$94.3K

Dambkowski Carl · Chief Medical…Apr 1

4,125 sh @ $22.86 · +2.0% own

SSELL◷$94K

Henderson Jane · Chief Financial…Apr 1

1,100 sh @ $85.46 · -0.6% own

SSELL◷$76K

Henderson Jane · Chief Financial…Apr 1

900 sh @ $84.46 · -0.5% own

SSELL◷$170K

Henderson Jane · Chief Financial…Mar 25

2,000 sh @ $85.00 · -1.1% own

SSELL◷$259.3K

Henderson Michael Thomas · Chief Executive…Mar 11

3,418 sh @ $75.86 · -0.3% own

SSELL◷$615K

Henderson Michael Thomas · Chief Executive…Mar 11

8,219 sh @ $74.83 · -0.7% own

SSELL◷$621.3K

Henderson Michael Thomas · Chief Executive…Mar 11

8,363 sh @ $74.29 · -0.7% own

MEXER◷◆—

Dambkowski Carl · Chief Medical…Mar 4

4,125 sh

SSELL◷$14.7K

Dambkowski Carl · Chief Medical…Mar 4

200 sh @ $73.26 · -0.1% own

SSELL◷$149.4K

Dambkowski Carl · Chief Medical…Mar 4

2,075 sh @ $71.98 · -1.0% own

SSELL◷$226.8K

Dambkowski Carl · Chief Medical…Mar 4

3,225 sh @ $70.33 · -1.5% own

MEXER◷$94.3K

Dambkowski Carl · Chief Medical…Mar 4

4,125 sh @ $22.86 · +1.9% own

SSELL◷$29.1K

Henderson Jane · Chief Financial…Mar 2

406 sh @ $71.66 · -0.2% own

SSELL◷$70K

Henderson Jane · Chief Financial…Mar 2

994 sh @ $70.45 · -0.5% own

SSELL◷$20.8K

Henderson Jane · Chief Financial…Mar 2

300 sh @ $69.43 · -0.2% own

SSELL◷$20.5K

Henderson Jane · Chief Financial…Mar 2

300 sh @ $68.27 · -0.2% own

SSELL◷$62.1K

Henderson Michael Thomas · Chief Executive…Feb 11

955 sh @ $64.99 · <0.1% own

SSELL◷$481.2K

Henderson Michael Thomas · Chief Executive…Feb 11

7,551 sh @ $63.73 · -0.6% own

SSELL◷$723.7K

Henderson Michael Thomas · Chief Executive…Feb 11

11,494 sh @ $62.96 · -1.0% own

MEXER◷◆—

Dambkowski Carl · Chief Medical…Feb 4

4,125 sh

SSELL◷$13.8K

Dambkowski Carl · Chief Medical…Feb 4

200 sh @ $68.94 · <0.1% own

SSELL◷$6.8K

Dambkowski Carl · Chief Medical…Feb 4

100 sh @ $67.88 · <0.1% own

SSELL◷$86.8K

Dambkowski Carl · Chief Medical…Feb 4

1,299 sh @ $66.85 · -0.6% own

SSELL◷$93.5K

Dambkowski Carl · Chief Medical…Feb 4

1,420 sh @ $65.83 · -0.7% own

SSELL◷$161K

Dambkowski Carl · Chief Medical…Feb 4

2,481 sh @ $64.88 · -1.1% own

MEXER◷$94.3K

Dambkowski Carl · Chief Medical…Feb 4

4,125 sh @ $22.86 · +1.9% own

SSELL◷$6.7K

Henderson Jane · Chief Financial…Feb 2

100 sh @ $66.89 · <0.1% own

SSELL◷$73.3K

Henderson Jane · Chief Financial…Feb 2

1,108 sh @ $66.15 · -0.6% own

SSELL◷$51.6K

Henderson Jane · Chief Financial…Feb 2

792 sh @ $65.21 · -0.4% own

SSELL$133.5M

Fairmount Funds… · DirectorJan 22

1.8M sh @ $76.30 · -85.4% own

SSELL◷$39.4K

Henderson Michael Thomas · Chief Executive…Jan 14

470 sh @ $83.79 · <0.1% own

SSELL◷$447.9K

Henderson Michael Thomas · Chief Executive…Jan 14

5,386 sh @ $83.16 · -0.4% own

SSELL◷$152.8K

Henderson Michael Thomas · Chief Executive…Jan 14

1,854 sh @ $82.41 · -0.1% own

SSELL◷$192.3K

Henderson Michael Thomas · Chief Executive…Jan 14

2,374 sh @ $81.00 · -0.2% own

SSELL◷$676.6K

Henderson Michael Thomas · Chief Executive…Jan 14

8,476 sh @ $79.82 · -0.7% own

SSELL◷$113.2K

Henderson Michael Thomas · Chief Executive…Jan 14

1,440 sh @ $78.64 · -0.1% own

MEXER◷◆—

Dambkowski Carl · Chief Medical…Jan 7

14,025 sh

SSELL◷$8K

Dambkowski Carl · Chief Medical…Jan 7

100 sh @ $80.06 · <0.1% own

SSELL◷$65.3K

Dambkowski Carl · Chief Medical…Jan 7

826 sh @ $79.04 · -0.4% own

SSELL◷$1.2M

Dambkowski Carl · Chief Medical…Jan 7

14,820 sh @ $77.90 · -6.5% own

SSELL◷$227.8K

Dambkowski Carl · Chief Medical…Jan 7

2,954 sh @ $77.13 · -1.3% own

MEXER◷$320.6K

Dambkowski Carl · Chief Medical…Jan 7

14,025 sh @ $22.86 · +6.5% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 57 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →